Gland Pharma Ltd
BSE: 543245
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.3K+2.0% | 1.3K+7.1% | 1.2K+9.6% | 1.1K+3.4% | 1.0K+0.8% | 1.0K+1.9% | 1.0K-4.9% | 1.1K |
| Other Income | 58.82-44.7% | 106.36+76.7% | 60.21-27.1% | 82.59+50.9% | 54.74+25.2% | 43.72-32.8% | 65.06+12.6% | 57.80 |
| Total Income | 1.3K-1.6% | 1.4K+10.5% | 1.2K+7.0% | 1.2K+5.8% | 1.1K+1.8% | 1.1K-0.2% | 1.1K-4.0% | 1.1K |
| EXPENSES | ||||||||
| Expenditure | 857.77+6.8% | 803.15+0.3% | 800.92+7.1% | 748.07+2.3% | 731.19+7.1% | 682.75+0.2% | 681.72-8.0% | 740.98 |
| Tax | 123.30-14.6% | 144.35+38.0% | 104.61-1.9% | 106.68+14.6% | 93.13-8.1% | 101.32+2.3% | 99.01+0.9% | 98.11 |
| PROFIT | ||||||||
| PBT | 487.69-13.7% | 564.80+36.9% | 412.46+0.9% | 408.67+12.8% | 362.38-7.4% | 391.32-0.7% | 394.13+3.8% | 379.82 |
| Net Profit | 364.39-13.3% | 420.45+36.6% | 307.85+1.9% | 302.00+12.2% | 269.26-7.2% | 290.00-1.7% | 295.12+4.8% | 281.71 |
| KEY METRICS | ||||||||
| OPM % | 36.80%-3.44pp | 40.24%+6.50pp | 33.74%-1.16pp | 34.90%+0.36pp | 34.54%-3.71pp | 38.25%+11.84pp | 26.41%+0.05pp | 26.36% |
| NPM % | 27.08%-3.66pp | 30.74%+5.87pp | 24.87%-1.24pp | 26.11%+1.49pp | 24.62%-2.38pp | 27.00%-0.43pp | 27.43%+2.30pp | 25.13% |
| EPS | 22.11-13.4% | 25.52+36.6% | 18.68+1.9% | 18.33+12.2% | 16.34-7.2% | 17.60-1.7% | 17.91+4.7% | 17.10 |
Corporate Events
Board MeetingGLAND
20266Nov
Board Meeting
The meeting of the Board of Directors will be held to consid…
BSE Filing ↗ Board MeetingGLAND
20261Oct
Board Meeting
The Board of Directors considered and approved an investment…
BSE Filing ↗ Board MeetingGLAND
202613Sep
Board Meeting
The Board of Directors has appointed Mr. William Keller as …
BSE Filing ↗ Board MeetingGLAND
202625Aug
Board Meeting
Notice of the 48th Annual General Meeting to adopt financial…
BSE Filing ↗ Board MeetingGLAND
202610Aug
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingGLAND
202630Jul
Board Meeting
The ESOP Compensation Committee of the Board of Directors of…
BSE Filing ↗ Board MeetingGLAND
202422May
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗ Board MeetingGLAND
202414Feb
Board Meeting
Consider and approve Unaudited financial Results
BSE Filing ↗ Board MeetingGLAND
20236Nov
Board Meeting
Consider and approve the Unaudited Standalone and Consolidat…
BSE Filing ↗